All Brands Owned by Takeda Pharmaceutical Company
Takeda Pharmaceutical Company owns 6 brands in our database. Browse the complete portfolio of Takeda Pharmaceutical Company subsidiaries and brands across various industries.
Company Type
public
Headquarters
Tokyo, Japan
Brand Portfolio
6 brands
Stock
Tokyo Stock Exchange: 4502
Filter by Category
Complete Brand Portfolio
Adcetris
Owned by Takeda Pharmaceutical Company
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.
Alofisel
Owned by Takeda Pharmaceutical Company
Prescription cell therapy for treating complex perianal fistulas in Crohn's disease, manufactured and marketed by Takeda Pharmaceutical Company.
Defitelio
Owned by Takeda Pharmaceutical Company
Prescription medication for treating hepatic sinusoidal obstruction syndrome, manufactured and marketed by Takeda Pharmaceutical Company.
Dexilant
Owned by Takeda Pharmaceutical Company
Prescription proton pump inhibitor for treating acid reflux and gastroesophageal reflux disease, manufactured and marketed by Takeda Pharmaceutical Company.
Entyvio
Owned by Takeda Pharmaceutical Company
Prescription biologic medication for treating inflammatory bowel disease including Crohn's disease and ulcerative colitis, manufactured and marketed by Takeda Pharmaceutical Company.
Envarsus
Owned by Takeda Pharmaceutical Company
Prescription immunosuppressant medication for preventing organ rejection in transplant recipients, manufactured and marketed by Takeda Pharmaceutical Company.
About Takeda Pharmaceutical Company
What does Takeda make?
Takeda makes prescription pharmaceuticals across four therapeutic areas: gastroenterology (Entyvio, Dexilant), oncology (Ninlaro, Adcetris), neuroscience (Vyvanse, Trintellix, Rozerem), and rare diseases. The company also produces plasma-derived therapies including immunoglobulins and albumin.
Is Takeda publicly traded?
Yes, Takeda Pharmaceutical Company Limited is listed on the Tokyo Stock Exchange under ticker 4502 and on the NYSE as an ADR under ticker TAK. The company has a broad institutional and retail shareholder base with no single controlling shareholder.
Who founded Takeda?
Takeda was founded in 1781 in Osaka, Japan by Chobei Takeda, who established a business selling traditional Japanese and Chinese medicines. The company has been in continuous operation for more than 240 years, making it one of the world's oldest pharmaceutical companies.
Where is Takeda headquartered?
Takeda is headquartered in Tokyo, Japan. The company's global operations span more than 80 countries, with its largest market being the United States. Takeda also has major operations in Europe, Japan, and emerging markets.
How many employees does Takeda have?
Takeda employs approximately 50,000 people worldwide. The company's workforce is distributed across research and development, manufacturing, and commercial operations in more than 80 countries.
Who owns Takeda?
Takeda Pharmaceutical Company Limited is publicly traded on the Tokyo Stock Exchange and NYSE with a broad institutional and retail shareholder base. No single shareholder holds a controlling stake. Christophe Weber serves as President and CEO.
Stock Information
Competitors to Takeda Pharmaceutical Company
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Sanofi | France | 2002 | Mass Market | Europe | All Genders | |
| Merck | USA | 2014 | Mass Market | North America | All Genders |
Learn More About Competitors
Eloxatin
Owned by Sanofi
Prescription chemotherapy medication for treating colorectal cancer, manufactured and marketed by Sanofi.
Keytruda
Owned by Merck & Co.
Prescription immunotherapy medication for treating various cancers by activating the immune system, manufactured and marketed by Merck & Co.
Competitive Analysis
Market Positioning: Takeda Pharmaceutical Company competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Takeda Pharmaceutical Company Brand Portfolio Overview
Takeda Pharmaceutical Company maintains a diverse portfolio of 6 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 6 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Takeda Pharmaceutical Companyprovides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Takeda Pharmaceutical Company
Latest News About Takeda Pharmaceutical Company
Articles About Takeda Pharmaceutical Company
View more articles
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?